Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes

Blood

Volumn 96, Issue 6, 2000, Pages 2240-2245

  Aguayo, Alvaro ^a   Kantarjian, Hagop ^a   Manshouri, Taghi ^a   Gidel, Cristi ^a   Estey, Elihu ^a   Thomas, Deborah ^a   Koller, Charles ^a   Estrov, Zeev ^a   O'Brien, Susan ^a   Keating, Michael ^a   Freireich, Emil ^a   Albitar, Maher ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; BASIC FIBROBLAST GROWTH FACTOR; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ANGIOGENESIS; ARTICLE; BONE MARROW BIOPSY; CHRONIC LEUKEMIA; CHRONIC LYMPHATIC LEUKEMIA; CHRONIC MYELOID LEUKEMIA; CHRONIC MYELOMONOCYTIC LEUKEMIA; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; METASTASIS; MYELODYSPLASTIC SYNDROME; PRIORITY JOURNAL;

EID: 0034665786     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.6.2240.h8002240_2240_2245     Document Type: Article

References (41)

1. Endothelial cells in physiology and in the pathophysiology of vascular disorders
2. Angiogenesis: An update
3. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis
4. Angiogenesis
5. Tumor angiogenesis: Therapeutic implications
6. Angiogenesis in cancer, vascular, rheumatoid and other disease
7. Angiogenesis and metastasis
8. Role of soluble mediators in angiogenesis
9. Vascular endothelial growth factor
10. The FGF family of growth factors and oncogenes
11. Interaction of high-molecular-weight basic fibroblast growth factor with endothelium: Biological activity and intracellular fate of human recombinant M(r) 24,000 bFGF
12. Basic fibroblast growth factor induces angiogenesis in vitro
13. In vitro angiogenesis on the human amniotic membrane: Requirement for basic fibroblast growth factor-induced proteinases
14. Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma
15. Pathogenesis of tumor stroma generation: A critical rote for leaky blood vessels and fibrin deposition
16. Are angiogenic factors, cytokines, and soluble adhesion molecules prognostic factors in patients with renal cell carcinoma?
17. A high pre-treatment serum vascular endothelial growth factor concentration is associated with poor outcome in non-Hodgkin's lymphoma
18. Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer
19. Different angiogenic pathways characterize superficial and invasive bladder cancer
20. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis, and proliferation of human colon cancer
21. Quantification of angiogenesis in solid human tumours: An international consensus on the methodology and criteria of evaluation
22. Clinical significance of the determination of angiogenesis in human breast cancer: Update of the biological background and overview of the Vicenza studies
23. Prognostic value of angiogenesis in gastro-intestinal tumours
24. Tumor angiogenesis: A new significant and independent prognostic indicator in early-stage breast carcinoma
25. Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma
26. Extent of vascularization as a prognostic indicator in thin (<0.76mm) malignant melanoma
27. Tumor angiogenesis in advanced stage ovarian carcinoma
28. Structure of the marrow
29. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia
30. Evidence of increased angiogenesis in patients with acute myeloid leukemia
31. Vascular endothelial growth factor, a possible paracrine growth factor in human acute myeloid leukemia
32. Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia
33. Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia
34. Clinical trials of antiangiogenic agents
35. Immunohistochemical localization of smooth muscle myosin in human spleen, lymph node, and other lymphoid tissues. Unique staining patterns in splenic white pulp and sinuses, lymphoid follicles, and certain vasculature, with ultrastructural correlations
36. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures
37. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections
38. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets: Significance for VEGF measurements and cancer biology
39. Elevated levels of angiogenic cytokines in the plasma of cancer patients
40. Angiogenesis in myelodysplastic syndromes
41. Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies